Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 13, 2025 09:30 ET | Source: Medigene AG

Medigene Files Patent for Unique NK-Specific TCR Construct with European Patent Office

Medigene AG (Medigene, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, today...
April 19, 2022 08:05 ET | Source: Aeterna Zentaris Inc

Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults

– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin® / Macrilen™ in Europe as the Company plans to pursue even greater protection TORONTO, ONTARIO,...
October 04, 2021 09:15 ET | Source: Adhera Therapeutics, Inc.

Adhera Receives European Patent Covering MLR-1019 and Derivatives for Treating Dyskinesias

Baton Rouge, LA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCPK: ATRX) ("Adhera" or the "Company"), a clinical stage biopharmaceutical company, is pleased to announce that a new...
November 24, 2020 07:30 ET | Source: CGE ENERGY, INC.

CGE Energy Granted Sixth Patent for Innovative Wind Turbine

BRIGHTON, Mich, Nov. 24, 2020 (GLOBE NEWSWIRE) -- CGE Energy, Inc. (OTCPink: CGEI) is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No....
July 24, 2018 06:30 ET | Source: Immuron Limited

Immuron Announces it has Received a European Patent Grant for NASH treatment

MELBOURNE, Australia, July 24, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ:IMRN) is an Australian microbiome biopharmaceutical Company focused on developing and commercializing orally...
February 22, 2018 09:00 ET | Source: Mount Tam Biotechnologies Inc.

Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01

NOVATO, CA , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased...
September 28, 2015 08:30 ET | Source: AIM ImmunoTech Inc.

Hemispherx Biopharma Receives the European Patent Office Grant of New Composition of Matter Patent Covering Ampligen(R) Formulations

PHILADELPHIA, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it received formal notice on September 21, 2015, that the...